|
Active substance |
Emicizumab |
|
Holder |
Roche |
|
Status |
Closed |
|
Indication |
Routine prophylaxis of bleeding episodes in patients with hemophilia A with factor VIII inhibitors. Hemlibra can be used in all age groups. |
|
Public documents |
|
|
Last update |
05/03/2020 |
Hemlibra
Last updated on 13/09/2024